Dr. Agarwal's Health Care

Dr. Agarwal's Health Care

422.90
-7.05
(-1.64%)
Market Cap
13,370.34 Cr
EPS
2.80
PE Ratio
131.41
Dividend Yield
0.00 %
Industry
-
52 Week High
494.50
52 Week Low
327.00
PB Ratio
7.28
Debt to Equity
0.93
Sector
-
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from3 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+66.67 %
+66.67 %
Hold
Hold+33.33 %
+33.33 %
Sell
Sell0.0 %
0.0 %

Automatic Screeners on ScanX

Forecast
Actual
Growth Rate
Revenue Growth
33.44 %
Net Income Growth
-7.85 %
Cash Flow Change
48.41 %
ROE
-56.00 %
ROCE
-1.67 %
EBITDA Margin (Avg.)
7.34 %

Quarterly Financial Results

Quarterly Financials
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Revenue
345
369
410
429
443
476
501
Expenses
244
241
300
310
316
332
360
EBITDA
101
128
110
119
128
144
141
Operating Profit %
27 %
31 %
26 %
26 %
27 %
28 %
26 %
Depreciation
43
47
56
57
58
60
63
Interest
22
27
27
28
28
25
25
Profit Before Tax
36
54
27
33
41
59
54
Tax
13
13
9
12
13
16
16
Net Profit
23
41
18
21
28
43
38
EPS in ₹
1.94
1.39
0.43
0.45
0.73
1.04
0.95

Balance Sheet

Balance Sheet
2021
2022
2023
2024
2025
Total Assets
787
1,026
1,825
2,753
3,672
Fixed Assets
575
702
1,293
1,746
1,942
Current Assets
155
228
310
759
794
Capital Work in Progress
11
28
99
118
144
Investments
0
0
34
471
80
Other Assets
201
296
399
418
0
Total Liabilities
787
1,026
1,825
2,753
3,672
Current Liabilities
150
206
301
400
478
Non Current Liabilities
438
586
865
974
1,267
Total Equity
199
234
659
1,380
1,867
Reserve & Surplus
177
206
622
1,330
1,835
Share Capital
7
7
8
9
32

Cash Flow

Cash Flow
2020
2021
2022
2023
2024
Net Cash Flow
-56
17
44
27
-15
Investing Activities
-85
-46
-155
-509
-914
Operating Activities
103
99
164
233
346
Financing Activities
-74
-37
35
303
553

Share Holding

% Holding
Sept 2024
Jan 2025
Feb 2025
Mar 2025
Jun 2025
Promoter
37.83 %
37.73 %
32.45 %
32.45 %
32.42 %
FIIs
0.00 %
0.00 %
56.97 %
60.62 %
59.26 %
DIIs
0.00 %
0.00 %
5.10 %
5.21 %
6.44 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
4.79 %
1.61 %
1.74 %
Others
62.17 %
62.27 %
0.69 %
0.11 %
0.14 %
No of Share Holders
29
43
2,17,289
68,696
63,021

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
24 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
24 Sept 2025 433.50 429.95
14 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Feb 2025 402.50 449.00
28 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 May 2025 401.60 375.25
12 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Aug 2025 445.90 446.20

Announcements

Announcement under Regulation 30 (LODR)-Newspaper Publication6 days ago
Announcement under Regulation 30 (LODR)-Earnings Call Transcript6 days ago
Letter Sent To Members Providing Weblink Of The Annual Report 2024-256 days ago
Reg. 34 (1) Annual Report.7 days ago
Annual Report For Financial Year 2024-25 And Notice For 15Th Annual General Meeting7 days ago
Annual Report For Financial Year 2024-25 And Notice For 15Th Annual General Meeting7 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 28, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 28, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationAug 27, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 27, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 27, 2025
Board Meeting Outcome for Approval Of Matters Under Regulation 30 Of SEBI (LODR) Regulations 2015Aug 27, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 19, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 16, 2025
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportAug 14, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 12, 2025
Unaudited Financial Results For The Quarter Ended June 30 2025Aug 12, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationAug 12, 2025
Board Meeting Outcome for Approval Of Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended June 30 2025Aug 12, 2025
Update On Earnings Call For Quarter Ended June 30 2025Aug 08, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 06, 2025
Board Meeting Intimation for Approval Of Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended June 30 2025Jul 30, 2025
Announcement under Regulation 30 (LODR)-Credit RatingJul 30, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 04, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jul 02, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jul 02, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 25, 2025
Closure of Trading WindowJun 25, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 24, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptJun 02, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 29, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationMay 29, 2025
Audited Financial Results (Standalone And Consolidated) For The Quarter And Year Ended March 31 2025May 28, 2025
Board Meeting Outcome for Approval Of Audited Financial Results (Standalone And Consolidated) For The Quarter And Year Ended March 31 2025May 28, 2025
Commencement Of Operations - New DelhiMay 27, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 24, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 21, 2025
Board Meeting Intimation for Approval Of Audited Financial Results (Standalone And Consolidated) For The Quarter And Year Ended March 31 2025May 20, 2025
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportMay 15, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSMay 14, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSApr 21, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 03, 2025
Commencement Of Operations Of New Branch - EluruMar 27, 2025
Closure of Trading WindowMar 27, 2025
Commencement Of Operations Of A New Branch - UdhnaMar 24, 2025
Commencement Of Operations Of A New Branch - DombivliMar 21, 2025
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015Mar 17, 2025
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015Mar 13, 2025
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015Mar 13, 2025
Commencement Of Operations Of A New Branch - GopalpatnamMar 12, 2025

Technical Indicators

RSI(14)
Neutral
45.50
ATR(14)
Less Volatile
18.90
STOCH(9,6)
Oversold
16.19
STOCH RSI(14)
Neutral
23.61
MACD(12,26)
Bearish
-3.75
ADX(14)
Weak Trend
24.50
UO(9)
Bearish
38.73
ROC(12)
Downtrend And Accelerating
-4.49
WillR(14)
Neutral
-70.22

Mutual Fund Holdings